Agilent Technologies Current Ratio 2010-2024 | A
Current and historical current ratio for Agilent Technologies (A) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Agilent Technologies current ratio for the three months ending July 31, 2024 was 1.78.
Agilent Technologies Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-07-31 |
$4.26B |
$2.39B |
1.78 |
2024-04-30 |
$4.20B |
$1.96B |
2.15 |
2024-01-31 |
$4.34B |
$1.62B |
2.68 |
2023-10-31 |
$4.19B |
$1.60B |
2.61 |
2023-07-31 |
$4.03B |
$1.76B |
2.29 |
2023-04-30 |
$3.95B |
$1.67B |
2.37 |
2023-01-31 |
$4.08B |
$1.94B |
2.11 |
2022-10-31 |
$3.78B |
$1.86B |
2.03 |
2022-07-31 |
$3.69B |
$1.90B |
1.94 |
2022-04-30 |
$3.64B |
$1.81B |
2.01 |
2022-01-31 |
$3.47B |
$1.58B |
2.19 |
2021-10-31 |
$3.80B |
$1.71B |
2.22 |
2021-07-31 |
$3.63B |
$1.72B |
2.11 |
2021-04-30 |
$3.51B |
$1.76B |
2.00 |
2021-01-31 |
$3.48B |
$1.69B |
2.07 |
2020-10-31 |
$3.42B |
$1.47B |
2.33 |
2020-07-31 |
$3.25B |
$1.31B |
2.47 |
2020-04-30 |
$3.17B |
$1.95B |
1.63 |
2020-01-31 |
$3.10B |
$1.89B |
1.64 |
2019-10-31 |
$3.19B |
$2.08B |
1.53 |
2019-07-31 |
$3.46B |
$1.62B |
2.13 |
2019-04-30 |
$3.81B |
$1.12B |
3.41 |
2019-01-31 |
$3.71B |
$1.10B |
3.39 |
2018-10-31 |
$3.85B |
$1.17B |
3.29 |
2018-07-31 |
$3.67B |
$1.01B |
3.62 |
2018-04-30 |
$4.53B |
$1.37B |
3.32 |
2018-01-31 |
$4.40B |
$1.36B |
3.23 |
2017-10-31 |
$4.17B |
$1.26B |
3.30 |
2017-07-31 |
$4.00B |
$1.24B |
3.22 |
2017-04-30 |
$3.80B |
$1.19B |
3.20 |
2017-01-31 |
$3.64B |
$1.09B |
3.34 |
2016-10-31 |
$3.64B |
$0.95B |
3.85 |
2016-07-31 |
$3.53B |
$1.15B |
3.07 |
2016-04-30 |
$3.49B |
$1.13B |
3.08 |
2016-01-31 |
$3.40B |
$0.95B |
3.59 |
2015-10-31 |
$3.69B |
$0.98B |
3.78 |
2015-07-31 |
$3.48B |
$0.85B |
4.08 |
2015-04-30 |
$3.62B |
$0.93B |
3.89 |
2015-01-31 |
$3.65B |
$0.93B |
3.94 |
2014-10-31 |
$5.51B |
$1.69B |
3.26 |
2014-07-31 |
$4.83B |
$1.58B |
3.06 |
2014-04-30 |
$5.38B |
$1.72B |
3.13 |
2014-01-31 |
$5.07B |
$1.55B |
3.28 |
2013-10-31 |
$4.98B |
$1.60B |
3.11 |
2013-07-31 |
$4.58B |
$1.55B |
2.96 |
2013-04-30 |
$4.82B |
$1.91B |
2.53 |
2013-01-31 |
$4.71B |
$1.85B |
2.55 |
2012-10-31 |
$4.63B |
$1.89B |
2.45 |
2012-07-31 |
$4.21B |
$2.09B |
2.02 |
2012-04-30 |
$6.01B |
$1.84B |
3.28 |
2012-01-31 |
$5.72B |
$1.71B |
3.35 |
2011-10-31 |
$5.57B |
$1.84B |
3.03 |
2011-07-31 |
$5.22B |
$1.51B |
3.47 |
2011-04-30 |
$5.10B |
$1.59B |
3.20 |
2011-01-31 |
$4.60B |
$1.41B |
3.27 |
2010-10-31 |
$6.17B |
$3.08B |
2.00 |
2010-07-31 |
$5.74B |
$2.92B |
1.97 |
2010-04-30 |
$5.71B |
$2.71B |
2.11 |
2010-01-31 |
$5.52B |
$2.55B |
2.17 |
2009-10-31 |
$3.96B |
$1.12B |
3.53 |
2009-07-31 |
$2.90B |
$0.99B |
2.92 |
2009-04-30 |
$2.88B |
$1.10B |
2.62 |
2009-01-31 |
$3.01B |
$1.13B |
2.66 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Electrical Test Equipment |
$38.462B |
$6.833B |
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|